中文名称  磷酸化酪氨酸激酶受体A抗体规格 

英文名称  Anti-Phospho-TrkA (Tyr791)

别    名 TrkA (Phospho-Tyr791); TrkA (Phospho Tyr791); TrkA (Phospho-Y791); p-TrkA(Tyr791); CIPA; CIPA; DKFZp781I14186; gp140trk; High affinity nerve growth factor receptor; High affinity nerve growth factor receptor precursor; High affinity nerve growth factor receptor precursor; MTC; MTC; neurotrophic tyrosine kinase receptor type 1; neurotrophic tyrosine kinase receptor type 1; Ntrk 1; Ntrk1; Ntrk1; NTRK1_HUMAN; Oncogene TRK; Oncogene TRK; p140 TrkA; p140-TrkA; TRK 1; Trk A; TRK; TRK; Trk-A; TRK1; TRK1 transforming tyrosine kinase protein; TRK1-transforming tyrosine kinase protein; Tropomyosin-related kinase A; Tyrosine kinase receptor A; Tyrosine kinase receptor; Tyrosine Receptor Kinase A.

产品属性：

磷酸化酪氨酸激酶受体A抗体规格 浓    度  1mg/1ml

规 格  0.1ml/100μg

抗体来源  Rabbit

克隆类型   polyclonal

交叉反应   Human, Mouse, Rat

产品类型   一抗 磷酸化抗体  

研究领域    细胞生物 免疫学 神经生物学 信号转导 转录调节因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 90kDa 

性    状   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human TrkA around the phosphorylation site of Tyr791

亚    型  IgG

纯化方法   affinity purified by Protein A

储 存 液   Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

磷酸化酪氨酸激酶受体A抗体规格 产品应用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200

（石蜡切片需做抗原修复） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存条件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

产品介绍 The Trk family of nerve growth factor receptors includes Trk A(also referfed to as Trk A gp140),Trk B and Trk C. The prototype member of this gene family, Trk A, encodes a 140 kDa cell surface receptor , gp140, the expression of which is restricted in vivo to neurons of the sensory spinal and cranial gangliaof neurocrest origin. Nerve growth factor (NGF) stimulates tyrosine phosphorylation of Trk gp 140 in neural cell lines and in embryonic dorsal root ganglia. By comparison, BDNF and to a lesser extent, NT-3, but not NGF, can induce tyrosine phophorylayion of Trk B gp 145. The third member of the Trk receptor family, Trk C incodes a 140 kDa protein, Trk C gp140, that is preferentially expressed in brain tissue and primarily functions as a receptor for NT-3.An additional component of the Trk receptor complex, NGFR p175, binds to neurotrophic factors with low affinity but is required for efficient signaling. NGFR p175 accelerates Trk activation and may recruit downstream dffector molecules to the ligand-bound receptor complex.

Function : Receptor tyrosine kinase involved in the development and the maturation of the central and peripheral nervous systems through regulation of proliferation, differentiation and survival of sympathetic and nervous neurons. High affinity receptor for NGF which is its primary ligand, it can also bind and be activated by NTF3/neurotrophin-3. However, NTF3 only supports axonal extension through NTRK1 but has no effect on neuron survival. Upon dimeric NGF ligand-binding, undergoes homodimerization, autophosphorylation and activation. Recruits, phosphorylates and/or activates several downstream effectors including SHC1, FRS2, SH2B1, SH2B2 and PLCG1 that regulate distinct overlapping signaling cascades driving cell survival and differentiation. Through SHC1 and FRS2 activates a GRB2-Ras-MAPK cascade that regulates cell differentiation and survival. Through PLCG1 controls NF-Kappa-B activation and the transcription of genes involved in cell survival. Through SHC1 and SH2B1 controls a Ras-PI3 kinase-AKT1 signaling cascade that is also regulating survival. In absence of ligand and activation, may promote cell death, making the survival of neurons dependent on trophic factors.

Isoform TrkA-III is resistant to NGF, constitutively activates AKT1 and NF-kappa-B and is unable to activate the Ras-MAPK signaling cascade. Antagonizes the anti-proliferative NGF-NTRK1 signaling that promotes neuronal precursors differentiation. Isoform TrkA-III promotes angiogenesis and has oncogenic activity when overexpressed.

Subunit : Exists in a dynamic equilibrium between monomeric (low affinity) and dimeric (high affinity) structures. Homodimerization is induced by binding of a NGF dimer. Interacts with SQSTM1; bridges NTRK1 to NGFR. Forms a ternary complex with NGFR and KIDINS220; this complex is affected by the expression levels of KIDINS220 and an increase in KIDINS220 expression leads to a decreased association of NGFR and NTRK1 (By similarity). Interacts with SH2D1A; regulates NTRK1 (By similarity). Interacts (phosphorylated upon activation by NGF) with SHC1; mediates SHC1 phosphorylation and activation. Interacts (phosphorylated upon activation by NGF) with PLCG1; mediates PLCG1 phosphorylation and activation. Interacts (phosphorylated) with SH2B1 and SH2B2. Interacts with GRB2. Interacts with PIK3R1. Interacts with FRS2. Interacts with SORT1; may regulate NTRK1 anterograde axonal transport. Interacts with RAB7A.

Subcellular Location : Cell membrane; Single-pass type I membrane protein. Early endosome membrane; Single-pass type I membrane protein. Note=Internalized to endosomes upon binding of NGF or NTF3 and further transported to the cell body via a retrograde axonal transport.

Tissue Specificity : Isoform TrkA-I is found in most non-neuronal tissues. Isoform TrkA-II is primarily expressed in neuronal cells. TrkA-III is specifically expressed by pluripotent neural stem and neural crest progenitors.

Post-translational modifications : Ligand-mediated autophosphorylation. Interaction with SQSTM1 is phosphotyrosine-dependent. Autophosphorylation at Tyr-496 mediates interaction and phosphorylation of SHC1.

N-glycosylated (Probable). Isoform TrkA-I is N-glycosylated.

Ubiquitinated. Undergoes polyubiquitination upon activation; regulated by NGFR. Ubiquitination regulates the internalization of the receptor (By similarity)

DISEASE : Defects in NTRK1 are a cause of congenital insensitivity to pain with anhidrosis (CIPA) [MIM:256800]. CIPA is characterized by a congenital insensitivity to pain, anhidrosis (absence of sweating), absence of reaction to noxious stimuli, self-mutilating behavior, and mental retardation. This rare autosomal recessive disorder is also known as congenital sensory neuropathy with anhidrosis or hereditary sensory and autonomic neuropathy type IV or familial dysautonomia type II.

Defects in NTRK1 are a cause of thyroid papillary carcinoma (TPC) [MIM:188550]. TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. Note=Chromosomal aberrations involving NTRK1 are found in thyroid papillary carcinomas. Translocation t(1;3)(q21;q11) with TFG generates the TRKT3 (TRK-T3) transcript by fusing TFG to the 3'-end of NTRK1; a rearrangement with TPM3 generates the TRK transcript by fusing TPM3 to the 3'-end of NTRK1; an intrachromosomal rearrangement that links the protein kinase domain of NTRK1 to the 5'-end of the TPR gene forms the fusion protein TRK-T1. TRK-T1 is a 55 kDa protein reacting with antibodies against the C-terminus of the NTRK1 protein.

Similarity : Belongs to the protein kinase superfamily. Tyr protein kinase family. Insulin receptor subfamily.

Contains 2 Ig-like C2-type (immunoglobulin-like) domains.

Contains 2 LRR (leucine-rich) repeats.

Contains 1 LRRCT domain.

Contains 1 protein kinase domain.

Database links : UniProtKB/Swiss-Prot: P04629.4

TrkA是NGF的功能性受体，当其与NGF结合后，可激活酪氨酸激酶信号传递系统，从而启动，产生生物效应。

实验流程：

全、新、优、品、好四大特点：

磷酸化酪氨酸激酶受体A抗体规格 全：公司提供上万种产品，涵盖了生物试剂，elisa试剂盒，标准品，培养基，原装耗材，抗体、培养基、ATCC细胞等，基本上各种科研所需产品在我司都能找到。

新：产品更新速度较快，基本上每周都有新产品出现。

优：产品质量好，投诉比较少。

好：我公司具有优质的技术团队，产品一旦售出，实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。

技术外包服务:

★磷酸化酪氨酸激酶受体A抗体规格 分子生物学：质粒抽提、PCR、Q-PCR、RT-PCR、分子生物学：基因合成、引物合成、基因测序、载体构建等

★蛋白工程：原核、哺乳动物蛋白表达系统等

★病毒包装：腺病毒、慢病毒等

★抗体工程：磁珠分选、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★细胞工程：细胞表型分析(凋亡、增殖、周期、迁移、侵袭、修复、克隆形成)、细胞培养、细胞膜制备、稳定细胞株构建、细胞RNAi技术等等。

正在热销的相关产品：

Anti-H1N1-A/HRP(Influenza A virus)California 辣根过氧化物酶标记兔抗季节性A型人病毒H1N1抗体IgG(美国加州型)Multi-class antibodies规格： 0.2ml

MT-II(Melanotan II Acetate) 醋酸美拉诺坦IIMulti-class antibodies规格： 1g

CD14/内毒素受体抗体 Anti-CD14 0.1ml

SYVN1 英文名称： 滑膜细胞凋亡抑制物1抗体 0.1ml

EphA7 英文名称： 酪酸蛋白激酶受体A7抗体 0.2ml

Rhesus antibody Rh phospho-HDAC1(Ser423+Ser421) 磷酸化组蛋白去乙酰化酶1抗体 规格 0.1ml

MT-II(Melanotan II Acetate) 醋酸美拉诺坦IIMulti-class antibodies规格： 1g

Anti-P-p38 ERK/MAPK14 /FITC 荧光素标记磷酸化-原活化蛋白激酶p38抗体IgGMulti-class antibodies规格： 0.2ml

Mouse Anti-human IgG Monoclonal Antibody/HRP 辣根过氧化物酶标记小鼠抗人IgG单克隆抗体Multi-class antibodies规格： 0.1ml

致癌基因抗体 Anti-C-Myc/MYC/MTLC 0.1ml

Mouse Anti-Rabbit IgM/Alexa Fluor 488 Alexa Fluor 488标记的小鼠抗兔IgM 0.1ml

Phospho-FOXO1 + FOXO3 + FOXO4 (phospho T24 + T32) 英文名称： 磷酸化叉头蛋白家族抗体 0.1ml

Rhesus antibody Rh PILR beta 细胞表面受体PILRβ抗体 规格 0.2ml

Mouse Anti-human IgG Monoclonal Antibody/HRP 辣根过氧化物酶标记小鼠抗人IgG单克隆抗体Multi-class antibodies规格： 0.1ml

P311 protein 相关蛋白(抗原)Multi-class antibodies规格： 0.5mg

Anti-CD54/ICAM-1 细胞间粘附分子-1抗体Multi-class antibodies规格： 0.1ml

Rhesus antibody Rh P38 MAPK(Phospho-Thr180/Tyr182) 磷酸化-原活化蛋白激酶p38抗体(P-p38 MAPK) 规格 0.1ml

IL1B Kit Human 人 IL-1 beta / IL1B / IL-1F2 ELISA配对抗体 ELISA

TUB 1 英文名称： TUB蛋白抗体 0.2ml

COBL 英文名称： -综合征相关COBL蛋白抗体 0.1ml

Anti-CD54/ICAM-1 细胞间粘附分子-1抗体Multi-class antibodies规格： 0.1ml

FASLG Protein Human 重组人 Fas Ligand / FASLG / CD95L 蛋白 (His 标签)

CNE-2 低分化细胞

ICOS Others Mouse 小鼠 ICOS / AILIM / CD278 人细胞裂解液 (阳性对照)

BxPC-3人原位*腺癌细胞 BxPC-3 in situ pancreatic adenocarcinoma cells 1640+10% FBS

小鼠细胞(分泌促生长激素分泌激素);AtT-20

人成纤维细胞( HCF) ( 5×105 ) GC-1, 鼠精原细胞 Mouse

CL-0456TM4(正常小鼠Sertoli细胞)5×106cells/瓶×2

SIGIRR Others Human 人 SIGIRR / TIR8 人细胞裂解液 (阳性对照)

人膀胱基质成纤维细胞RNAHBdSF miRNA5 μg

T24细胞，人膀胱移行细胞癌细胞 大鼠细胞(wistar 大鼠),CBRH7919细胞 RN-c, 大鼠皮质神经元

Ishikawa(人细胞) 5×106cells/瓶×2

hPC-PL-c 人类胎盘周细胞(hPC-PL) 500,000cells 小鼠巨噬细胞MMa

磷酸化酪氨酸激酶受体A抗体规格 FASLG Protein Human 重组人 Fas Ligand / FASLG / CD95L 蛋白 (His 标签)

CNE-2 低分化细胞

ICOS Others Mouse 小鼠 ICOS / AILIM / CD278 人细胞裂解液 (阳性对照)

BxPC-3人原位*腺癌细胞 BxPC-3 in situ pancreatic adenocarcinoma cells 1640+10% FBS

小鼠细胞(分泌促生长激素分泌激素);AtT-20

人成纤维细胞( HCF) ( 5×105 ) GC-1, 鼠精原细胞 Mouse